TRPV3 drives lung injury by sensing inflammatory signals to disrupt alveolar epithelial barrier and promote inflammation
Related Experiment Video
Updated: Oct 11, 2026

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents
Published on: December 5, 2025
Chuchu Xi1,2,3, Fang Zhao1,2, Lin Li1,2
1Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing, China.
Background And Purpose:
Pulmonary inflammation is a central pathological feature of many respiratory diseases. Transient receptor potential vanilloid 3 (TRPV3), a non-selective cation channel abundantly expressed in the skin, nerve and lung tissues, is involved in itch, skin inflammation and barrier regulation. However, its function in the pulmonary system remains elusive. We aimed to determine whether and how TRPV3 is involved in pulmonary inflammation.
Experimental Approach:
Lipopolysaccharide (LPS) and carvacrol were used to model acute lung injury (ALI) in C57BL/6J mice. Histology, bronchoalveolar lavage fluid analysis, qPCR, Western blotting, immunofluorescence, Ca2+ imaging, transepithelial electrical resistance and FITC-dextran permeability assays were used to assess inflammatory cell infiltration, cytokine expression, intracellular Ca2+ changes and epithelial barrier integrity.
Key Results:
TRPV3 expression is markedly up-regulated in lung tissues of ALI mice. Pharmacological activation of TRPV3 by carvacrol triggers features of ALI. Genetic deletion or pharmacological inhibition of TRPV3 significantly attenuated LPS- or carvacrol-induced lung injury. Activating TRPV3 in cultured alveolar epithelial cells increased intracellular Ca2+, boosted cytokine/chemokine production, disrupted tight junctions, reduced transepithelial electrical resistance and increased epithelial permeability. TNF-α augmented TRPV3 Ca2+ responses, and inhibition of TRPV3 activity or suppression of TRPV3 expression abolished TNF-α-induced production of cytokines/chemokines and tight junction disruption.
Conclusions And Implications:
TRPV3 senses inflammatory signals to augment inflammation and disrupt tight junctions in alveolar epithelial cells, making it a promising molecular target to develop treatments for pulmonary inflammation.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Acute Inflammation III: Local and Systemic Effects
Pneumonia I: Introduction
Acute Inflammation I: Inflammatory Response
Inflammatory Bowel Disease III: Crohn's Disease
